Compare Royal Bank of Canada (RY) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Bank of Canada vs Sanofi SA — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Royal Bank of Canada is far larger — about 2.8× Sanofi SA's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| RY | SNY | |
|---|---|---|
Market Cap | $289.51B | $104.83B |
Sector | Financials | Health |
52-Week High | $217.87 | $52.34 |
52-Week Low | $128.46 | $41.33 |
Dividend Yield | 2.42% | 5.5% |
Enterprise Value | — | $121.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
